Article

State of Science Summit- Lung Cancer: Chaired by Sarah Goldberg, MD, MPH & Roy S. Herbst, MD, PhD

State of Science Summit- Lung Cancer: Chaired by Sarah Goldberg, MD, MPH & Roy S. Herbst, MD, PhD

State of Science Summit- Lung Cancer: Chaired by Sarah Goldberg, MD, MPH & Roy S. Herbst, MD, PhD

Speakers

  • Scott Gettinger, MD | Yale Cancer Center Smilow Cancer Center Hospital
  • Anne Chiang, MD, PhD | Yale Cancer Center Smilow Cancer Center Hospital
  • Justin Blasberg, MD, MPH, FACS | Yale Cancer Center Smilow Cancer Center Hospital
  • Henry S. Park, MD, MPH | Yale Cancer Center Smilow Cancer Center Hospital
  • Michael Cohenuram, MD | Yale Cancer Center Smilow Cancer Center Hospital
  • So Yeon Kim, MD | Yale Cancer Center Smilow Cancer Center Hospital

Topics

  • Recent Updates in the Treatment of Metastatic NSCLC
  • EGFR: Adjuvant to Metastatic
  • Managing SCLC
  • Novel Agents and Emerging Targets in Lung Cancer
  • Case discussion: Early-Stage Lung Cancer

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Ben Levy, MD, and Yan Leyfman, MD
BDTX-1535 – A MasterKey EGFR Inhibitor Targeting Classical, Non-Classical, and the C797S Resistance Mutation To Address The Evolved Landscape Of EGFR Mutant NSCLC
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Video 14 - "Key Takeaways in HER2-Mutated NSCLC"
Video 13 - "Treatment Considerations in HER2-Mutated NSCLC"
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
Zofia Piotrowska, MD, MHS, and Martin Dietrich, MD, PhD, experts on lung cancer
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Amin Nassar, MD